Article
Loss of heterozygosity analysis in malignant gliomas.
Brain tumor pathology - 1 Jul 2011
Mizoguchi Masahiro, Kuga Daisuke, Guan Yanlei, Hata Nobuhiro, Nakamizo Akira, Yoshimoto Koji, Sasaki Tomio
Abstract excerpt
Despite recent advances in the diagnosis and treatment of glioblastomas, patient outcomes for these highly malignant tumors remain poor. Research into the molecular pathology of glioblastoma has uncovered various genetic changes that contribute to malignancy. Some of the identified molecular markers--such as loss of heterozygosity (LOH) on chromosome 1p/19q and chromosome 10, O6-methylguanine methyltransferase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
